Personalised Therapy in Type 2 Diabetes | Long Questions | Diabetes Pharmacology

Personalized Therapy in Type 2 Diabetes Mellitus | Individualized Antidiabetic Drug Selection Choosing the right antidiabetic drug is no longer based on blood glucose alone. Modern diabetes management focuses on the individual patient—considering body weight, hypoglycemia risk, cardiovascular disease, kidney function, and severity of hyperglycemia. In this video, we discuss a practical and examination-oriented approach to Personalized Therapy in Type 2 Diabetes Mellitus, helping you understand which drugs to prefer and which to avoid in different clinical scenarios. 📌 Topics Covered: ✅ Overweight & Obese Patients Why Metformin remains first-line therapy Role of GLP-1 Receptor Agonists in weight loss Benefits of SGLT-2 Inhibitors Why Sulfonylureas, TZDs, and Insulin may worsen weight gain ✅ Patients at High Risk of Hypoglycemia Safe options: Metformin, DPP-4 Inhibitors, SGLT-2 Inhibitors, GLP-1 Agonists, TZDs Drugs associated with hypoglycemia Special considerations in elderly patients and those with irregular meals ✅ Type 2 Diabetes with Established Cardiovascular Disease Cardiovascular benefits of SGLT-2 Inhibitors Cardiovascular outcome benefits of GLP-1 Receptor Agonists Why Pioglitazone should be avoided in Heart Failure ✅ Chronic Kidney Disease (CKD) Renoprotective effects of SGLT-2 Inhibitors Role of GLP-1 Receptor Agonists Why Linagliptin is preferred among DPP-4 inhibitors Metformin and Sulfonylurea precautions in renal impairment ✅ Severe Hyperglycemia When HbA1c exceeds 10% When blood glucose exceeds 300 mg/dL Why early Insulin Therapy is recommended Risks of delaying insulin initiation ✅ Drug Selection at a Glance Quick revision table for exams and clinical practice 🎯 Ideal for: MBBS Students BDS Students Nursing Students Pharmacy Students Pharmacology Postgraduates Medical Entrance & University Exam Preparation If you found this video helpful, please Like, Share, and Subscribe to Pharmacology Essentials Dot Com for concise, exam-oriented pharmacology learning. #Type2Diabetes #DiabetesManagement #AntidiabeticDrugs #Metformin #GLP1Agonists #SGLT2Inhibitors #DPP4Inhibitors #InsulinTherapy #DiabetesPharmacology #Pharmacology #MBBS #MedicalEducation #NEETPG #FMGE #INICET #USMLE